Skip to main content
SpringerLink
Log in

Mirk/Dyrk 1B

A multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival

  • Review
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Minibrain-related kinase (Mirk)/dual-specificity tyrosine-regulated kinase (Dyrk)1B is one of the best functionally characterized members of the Dyrk/Minibrain family of dual-specificity kinases. Dyrk family kinases are highly conserved mediators of growth control and differentiation. Mirk is expressed at high levels in skeletal muscle; thus, most of the recent studies of Mirk have used myogenesis as a model system to explore the function of Mirk in a native physiological environment. These studies have revealed that Mirk is a multifunctional Ser/Thr kinase that plays a critical role in muscle differentiation by regulatory effects on motility, transcription, cell cycle progression, and cell survival. Mirk also is found at elevated levels in various solid tumors, where it seems to act as a tumor survival factor. This review summarizes the known regulators and functions of Mirk kinase and outlines opportunities for future studies of Mirk in the fields of muscle and tumor biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Becker, W., Weber, Y., Wetzel, K., Eirmbter, K., Tejedor, F., and Joost, H.-G. (1998) Sequence characteristics, subcellular localization and substrate specificity of Dyrk-related kinases, a novel family of dual specificity protein kinases. J Biol Chem. 273, 25,893–25,902.

    CAS  Google Scholar 

  2. Lee, K. and Friedman, E. (1998) Novel dual-specific tyrthr/ser kinase cloned from colon carcinoma cells. Proc AACR. 39, 273.

    Google Scholar 

  3. Lee, K., Deng, X., and Friedman, E. (2000) Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. Cancer Res. 60, 3631–3637.

    PubMed  CAS  Google Scholar 

  4. Leder, S., Weber, Y., Altafai, X., Estivill, X., Joost, H. G., and Becker, W. (1999) Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases. Biochem. Biophys. Res. Commun. 254, 474–479.

    Article  PubMed  CAS  Google Scholar 

  5. Kentrup, H., Becker, W., Heukelbach, J., et al. (1996) Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J. Biol. Chem. 271, 3488–3495.

    Article  PubMed  CAS  Google Scholar 

  6. Becker, W. and Joost, H. G. (1999) Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog. Nucleic Acids Res. Mol. Biol. 62, 1–17.

    Article  CAS  Google Scholar 

  7. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912–1934.

    Article  PubMed  CAS  Google Scholar 

  8. Jope, R. S. and Johnson, G. V. (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95–102.

    Article  PubMed  CAS  Google Scholar 

  9. Muraki, M., Ohkawara, B., Hosoya, T., et al. (2004) Manipulation of alternative splicing by a newly developed inhibitor of Clks. J. Biol. Chem. 279, 24,246–24,254.

    Article  CAS  Google Scholar 

  10. Duncan, P. I., Stojdl, D. F., Marius, R. M., and Bell, J. C. (1997) In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Mol. Cell. Biol. 17, 5996–6001.

    PubMed  CAS  Google Scholar 

  11. Myers, M. P., Murphy, M. B., and Landreth, G. (1994) The dual-specificity CLK kinase induces neuronal differentiation of PC12 cells. Mol. Cell. Biol. 14, 6954–6961.

    PubMed  CAS  Google Scholar 

  12. Kannan, N. and Neuwald, A. F. (2004) Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha. Protein Sci. 13, 2059–2077.

    Article  PubMed  CAS  Google Scholar 

  13. Kuroyanagi, N., Onogi, H., Wakabayashi, T., and Hagiwara, M. (1998) Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles. Biochem. Biophys. Res. Commun. 242, 357–364.

    Article  PubMed  CAS  Google Scholar 

  14. Wang, A., Forman-Kay, J., Luo, Y., et al. (1997) Identification and characterization of human genes encoding Hprp3p and Hprp4p, interacting components of the spliceosome. Hum. Mol. Genet. 6, 2117–2126.

    Article  PubMed  CAS  Google Scholar 

  15. Gross, T., Lutzelberger, M., Weigmann, H., Klingenhoff, A., Shenoy, S., and Kaufer, N. F. (1997) Functional analysis of the fission yeast Prp4 protein kinase involved in pre-mRNA splicing and isolation of a putative mammalian homologue. Nucleic Acids Res. 25, 1028–1035.

    Article  PubMed  CAS  Google Scholar 

  16. Wang, H. Y., Lin, W., Dyck, J. A., et al. (1998) SRPK2: a differentially expressed SR protein-specific kinase involved in mediating the interaction and localization of pre-mRNA splicing factors in mammalian cells. J. Cell Biol. 140, 737–750.

    Article  PubMed  CAS  Google Scholar 

  17. Kim, Y. H., Choi, C. Y., Lee, S. J., Conti, M. A., and Kim, Y. (1998) Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J. Biol. Chem. 273, 25,875–25,879.

    CAS  Google Scholar 

  18. Guimera, J., Casas, C., Estivill, X., and Pritchard, M. (1999) Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression and overexpression in Down syndrome. Genomics 57, 407–418.

    Article  PubMed  CAS  Google Scholar 

  19. Tejedor, F., Zhu, X. R., Kaltenbach, E., et al. (1995) Minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron 14, 287–301.

    Article  PubMed  CAS  Google Scholar 

  20. Galceran, J., de Graaf, K., Tejedor, F. J., and Becker, W. (2003) The MNB/DYRK1A protein kinase: genetic and biochemical properties. J. Neural Transm. Suppl. 67, 139–148.

    PubMed  CAS  Google Scholar 

  21. Hammerle, B., Elizalde, C., Galceran, J., Becker, W., and Tejedor, F. J. (2003) The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications. J. Neural. Transm. Suppl. 67, 129–137.

    PubMed  Google Scholar 

  22. Altafaj, X., Dierssen, M., Baamonde, C., et al. (2001) Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum. Mol. Genet. 10, 1915–1923.

    Article  PubMed  CAS  Google Scholar 

  23. Fotaki, V., Dierssen, M., Alcantara, S., et al. (2002) Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol. Cell Biol. 22, 6636–6647.

    Article  PubMed  CAS  Google Scholar 

  24. Fotaki, V., Martinez De Lagran, M., Estivill, X., Arbones, M., and Dierssen, M. (2004) Haploinsufficiency of Dyrk1A in mice leads to specific alterations in the development and regulation of motor activity. Behav. Neurosci. 118, 815–821.

    Article  PubMed  CAS  Google Scholar 

  25. Yang, E., Ahn, Y. S., and Chung, K. (2001) Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells. J. Biol. Chem. 276, 39,819–39,824.

    CAS  Google Scholar 

  26. Wiechmann, S., Czajkowska, H., de Graaf, K., Grotzinger, J., Joost, H. G., and Becker, W. (2003) Unusual function of the activation loop in the protein kinase DYRK1A. Biochem. Biophys. Res. Commun. 302, 403–408.

    Article  PubMed  CAS  Google Scholar 

  27. Matsuo, R., Ochiai, W., Nakashima, K., and Taga, T. (2001) A new expression cloning strategy for isolation of substrate-specific kinases by using phosphorylation site-specific antibody. J. Immunol. Methods 247, 141–151.

    Article  PubMed  CAS  Google Scholar 

  28. Mao, J., Maye, P., Kogerman, P., et al. (2002) Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J. Biol. Chem. 277, 35,156–35,161.

    CAS  Google Scholar 

  29. von Groote-Bidlingmaier, F., Schmoll, D., Orth, H. M., Joost, H. G., Becker, W., and Barthel, A. (2003) DYRK1 is a co-activator of FKHR (FOXO1a)-dependent glucose-6-phosphatase gene expression. Biochem. Biophys. Res. Commun. 300, 764–769.

    Article  Google Scholar 

  30. Woods, Y. L., Rena, G., Morrice, N., et al. (2001) The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J. 355, 597–607.

    PubMed  CAS  Google Scholar 

  31. Woods, Y. L., Cohen, P., Becker, W., et al. (2001) The kinase DYRK phosphorylates protein-synthesis initiation factor elF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem. J. 355, 609–615.

    PubMed  CAS  Google Scholar 

  32. Chen-Hwang, M. C., Chen, H. R., Elzinga, M., and Hwang, Y. W. (2002) Dynamin is a minibrain kinase/dual specificity Yak1-related kinase 1A substrate. J. Biol. Chem. 277, 17,597–17,604.

    Article  CAS  Google Scholar 

  33. de Graaf, K., Hekerman, P., Spelten, O., et al. (2004) Characterization of cyclin L2, a novel cyclin with an arginine/serine-rich domain: phosphorylation by DYRK1A and colocalization with splicing factors. J. Biol. Chem. 279, 4612–4624.

    Article  PubMed  Google Scholar 

  34. Miller, C. T., Aggarwal, S., Lin, T. K., et al. (2003) Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas. Cancer Res. 63, 4136–4143.

    PubMed  CAS  Google Scholar 

  35. Geiger, J. N., Knudsen, G. T., Panek, L., et al. (2001) mDYRK3 kinase is expressed selectively in late erythroid progenitor cells and attenuates colony-forming unit-erythroid development. Blood 97, 901–910.

    Article  PubMed  CAS  Google Scholar 

  36. Zhang, D., Li, K., Erickson-Miller, C. L., Weiss, M., and Wojchowski, D. M. (2005) DYRK gene structure and erythroid-restricted features of DYRK3 gene expression. Genomics 85, 117–130.

    Article  PubMed  CAS  Google Scholar 

  37. Lord, K. A., Creasy, C. L., King, A. G., et al. (2000) REDK, a novel human regulatory erythyroid kinase. Blood 95, 2838–2846.

    PubMed  CAS  Google Scholar 

  38. Li, K., Zhao, S., Karur, V., and Wojchowski, D. M. (2002) DYRK3 activation, engagement of protein kinase A/cAMP response element-binding protein, and modulation of progenitor cell survival. J. Biol. Chem. 277, 47,052–47,060.

    CAS  Google Scholar 

  39. Mercer, S. E., Ewton, D. Z., Deng, X., Lim, S., Mazur, T. R., and Friedman, E. (2005) Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts. J. Biol. Chem. 280, 25,788–25,801.

    Article  CAS  Google Scholar 

  40. Mackeigan, J. P., Murphy, L. O., and Blenis, J. (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat. Cell Biol. 7, 591–600.

    Article  PubMed  CAS  Google Scholar 

  41. Leypoldt, F., Lewerenz, J., and Methner, A. (2001) Identification of genes up-regulated by retinoic-acid-induced differentiation of the human neuronal precursor cell line NTERA-2 clD1. J. Neurochem. 76, 806–814.

    Article  PubMed  CAS  Google Scholar 

  42. Lochhead, P. A., Sibbet, G., Kinstrie, R., Cleghon, T., Rylatt, M., Morrison, D. K., and Cleghon, V. (2003) dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila. Biochem. J. 374, 381–391.

    Article  PubMed  CAS  Google Scholar 

  43. Raich, W. B., Moorman, C., Lacefield, C. O., et al. (2003) Characterization of Caenorhabditis elegans homologs of the Down syndrome candidate gene DYRK1A. Genetics 163, 571–580.

    PubMed  CAS  Google Scholar 

  44. Pang, K. M., Ishidate, T., Nakamura, K., et al. (2004) The minibrain kinase homolog, mbk-2, is required for spindle positioning and asymmetric cell division in early C. elegans embryos. Dev. Biol. 265, 127–139.

    Article  PubMed  CAS  Google Scholar 

  45. Kassis, S., Melhuish, T., Annan, R. S., et al. (2000) Saccharomyces cerevisiae Yak1p protein kinase autophosphorylates on tyrosine residues and phosphorylates myelin basic protein on a C-terminal serine residue. Biochem. J. 348, 263–272.

    Article  PubMed  CAS  Google Scholar 

  46. Moriya, H., Shimizu-Yoshida, Y., Omori, A., Iwashita, S., Katoh, M., and Sakai, A. (2001) Yak1p, a DYRK family kinase, translocates to the nucleus and phosphorylates yeast Pop2p in response to a glucose signal. Genes Dev. 150, 1217–1228.

    Article  Google Scholar 

  47. Bahler, J. and Pringle, J. R. (1998) Pomlp, a fission yeast protein kinase that provides positional information for both polarized growth and cytokinesis. Genes Dev. 12, 1356–1370.

    PubMed  CAS  Google Scholar 

  48. Taminato, A., Bagattini, R., Gorjao, R., Chen, G., Kuspa, A., and Souza, G. M. (2002) Role for YakA, cAMP, and protein kinase A in regulation of stress responses of Dictyostelium discoideum. Mol. Biol. Cell. 13, 2266–2275.

    Article  PubMed  CAS  Google Scholar 

  49. Garrett, S. and Broach, J. (1989) Loss of Ras activity in Saccharomyces cerevisiae is suppressed by disruptions of a new kinase gene, YAKI, whose product may act downstream of the cAMP-dependent protein kinase. Genes Dev. 3, 1336–1348.

    Article  PubMed  CAS  Google Scholar 

  50. Garrett, S., Menold, M. M., and Broach, J. R. (1991) The Saccharomyces cerevisiae YAK1 gene encodes a protein kinase that is induced by arrest early in the cell cycle. Mol. Cell. Biol. 11, 4045–4052.

    PubMed  CAS  Google Scholar 

  51. Bahler, J. and Nurse, P. (2001) Fission yeast Pom1p kinase activity is cell cycle regulated and essential for cellular symmetry during growth and division. EMBO J. 20, 1064–1073.

    Article  PubMed  CAS  Google Scholar 

  52. Souza, G. M., da Silva, A. M., and Kuspa, A. (1999) Starvation promotes Dictyostelium development by relieving PufA inhibition of PKA translation through the YakA kinase pathway. Development 126, 3263–3274.

    PubMed  CAS  Google Scholar 

  53. Alvarez, M., Estivill, X., and de la Luna, S. (2003) DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. J. Cell Sci. 116, 3099–3107.

    Article  PubMed  CAS  Google Scholar 

  54. Hammerle, B., Carnicero, A., Elizalde, C., Ceron, J., Martinez, S., and Tejedor, F. J. (2003) Expression patterns and subcellular localization of the Down syndrome candidate protein MNB/DYRK1A suggest a role in late neuronal differentiation. Eur. J. Neurosci. 17, 2277–2286.

    Article  PubMed  CAS  Google Scholar 

  55. Marti, E., Altafaj, X., Dierssen, M., et al. (2003) Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res. 964, 250–263.

    Article  PubMed  CAS  Google Scholar 

  56. Wegiel, J., Kuchna, I., Nowicki, K., et al. (2004) Cell type-and brain structure-specific patterns of distribution of minibrain kinase in human brain. Brain Res. 1010, 69–80.

    Article  PubMed  CAS  Google Scholar 

  57. Deng, X., Ewton, D. Z., Li, S. (2006) The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma. Cancer Res. in press.

  58. Mercer, S. E., Ewton, D. Z., Shah, S., Naqvi, A. and Friedman, E. (2006) Mirk/Dyrk 1B mediates cell wurvival in rabdomyosarcomas. Cancer Res., in press.

  59. Miyata, Y. and Nishida, E. (1999) Distantly related cousins of MAP kinase: biochemical properties and possible physiological functions. Biochem. Biophys. Res. Commun. 266, 291–295.

    Article  PubMed  CAS  Google Scholar 

  60. Himpel, S., Panzer, P., Eirmbter, K., et al. (2001) Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem. J. 359, 497–505.

    Article  PubMed  CAS  Google Scholar 

  61. Lochhead, P. A., Sibbet, G., Morrice, N., and Cleghon, V. (2005) Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 121, 925–936.

    Article  PubMed  CAS  Google Scholar 

  62. Campbell, L. E. and Proud, C. G. (2002) Differing substrate specificities of members of the DYRK family of arginine-directed protein kinases. FEBS Lett 510, 31–36.

    Article  PubMed  CAS  Google Scholar 

  63. Himpel, S., Tegge, W., Frank, R., Leder, S., Joost, H. G., and Becker, W. (2000) Specificity determinants of substrate recognition by the protein kinase DYRK1A. J. Biol. Chem. 275, 2431–2438.

    Article  PubMed  CAS  Google Scholar 

  64. Deng, X., Mercer, S. E., Shah, S., Ewton, D. Z., and Friedman, E. (2004) The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/Dyrk1B kinase. J. Biol. Chem. 279, 22,498–22,504.

    CAS  Google Scholar 

  65. Deng, X., Ewton, D. Z., Mercer, S. E., and Friedman, E. (2005) Mirk/Dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation. J. Biol. Chem. 280, 4894–4905.

    Article  PubMed  CAS  Google Scholar 

  66. Lim, S., Jin, K., and Friedman, E. (2002) Mirk protein kinase is activated by MKK3 and functions as a transcriptional activator of HNF1alpha. J. Biol. Chem. 277, 25,040–25,046.

    CAS  Google Scholar 

  67. Zou, Y., Ewton, D. Z., Deng, X., Mercer, S. E., and Friedman, E. (2004) Mirk/Dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288. J. Biol. Chem. 279, 27,790–27,798.

    CAS  Google Scholar 

  68. Skurat, A. V. and Dietrich, A. D. (2004) Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family protein kinases. J. Biol. Chem. 279, 2490–2498.

    Article  PubMed  CAS  Google Scholar 

  69. Leder, S., Czajkowska, H., Maenz, B., et al. (2003) Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties. Biochem. J. 372, 881–888.

    Article  PubMed  CAS  Google Scholar 

  70. Deng, X., Ewton, D., Pawlikowski, B., Maimone, M., and Friedman, E. (2003) Mirk/Dyrk1B is a rho-induced kinase active in skeletal muscle differentiation. J. Biol. Chem. 278, 41,347–41,354.

    CAS  Google Scholar 

  71. Rogers, S., Wells, R., Rechsteiner, M. (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234, 364–368.

    Article  PubMed  CAS  Google Scholar 

  72. Rechsteiner, M. and Rogers, S. W. (1996) PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21, 267–271.

    Article  PubMed  CAS  Google Scholar 

  73. Lim, S., Zou, Y., and Friedman, E. (2002) The transcriptional activator Mirk/Dyrk1B is sequestered by p38alpha/beta MAP kinase. J. Biol. Chem. 277, 49,438–49,445.

    CAS  Google Scholar 

  74. Nadal-Ginard, B., Kajstura, J., Leri, A., and Anversa, P. (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ. Res. 92, 139–150.

    Article  PubMed  CAS  Google Scholar 

  75. Solloway, M. J. and Harvey, R. P. (2003) Molecular pathways in myocardial development: a stem cell perspective. Cardiovasc. Res. 58, 264–277.

    Article  PubMed  CAS  Google Scholar 

  76. Urbanek, K., Quaini, F., Tasca, G., et al. (2003) Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 100, 10,440–10,445.

    Article  CAS  Google Scholar 

  77. Beltrami, A. P., Barlucchi, L., Torella, D., et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763–776.

    Article  PubMed  CAS  Google Scholar 

  78. Ewton, D. Z., Lee, K., Deng, X., Lim, S., and Friedman, E. (2003) Rapid turnover of cell-cycle regulators found in Mirk/Dyrk1B transfectants. Int. J. Cancer 103, 21–28.

    Article  PubMed  CAS  Google Scholar 

  79. Lu, J., McKinsey, T. A., Nicol, R. L., and Olson, E. N. (2000) Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA 97, 4070–4075.

    Article  PubMed  CAS  Google Scholar 

  80. McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2001) Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11, 497–504.

    Article  PubMed  CAS  Google Scholar 

  81. Lu, J., McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2000) Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell 6, 233–244.

    Article  PubMed  CAS  Google Scholar 

  82. Asada, M., Yamada, T., Ichijo, H., et al. (1999) Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18, 1223–1234.

    Article  PubMed  CAS  Google Scholar 

  83. Zhou, B., Liao, Y., Xia, W., Lee, M.-H., and Hung, M.-C. (2001) Cytoplasmic localization of p21cip1/waf1 by Aktinduced phosphorylation in HER-2/Neu-overexpressing cells. Nat. Cell Biol. 3, 245–252.

    Article  PubMed  CAS  Google Scholar 

  84. Xia, W., Chen, J. S., Zhou, X., et al. (2004) Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin. Cancer Res. 10, 3815–3824.

    Article  PubMed  CAS  Google Scholar 

  85. Blagosklonny, M. V. (2002) Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 1, 391–393.

    PubMed  CAS  Google Scholar 

  86. Wang J. and Walsh, K. (1996) Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359–361.

    Article  PubMed  CAS  Google Scholar 

  87. Tanaka, H., Yamashita, T., Asada, M., Mizutani, S., Yoshikawa, H., and Tohyama, M. (2002) Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J. Cell Biol. 158, 321–329.

    Article  PubMed  CAS  Google Scholar 

  88. Tanaka, H., Yamashita, T., Yachi, K., Fujiwara, T., Yoshikawa, H., and Tohyama, M. (2004) Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. Neuroscience 127, 155–164.

    Article  PubMed  CAS  Google Scholar 

  89. Merlino, G. and Helman, L. J. (1999) Rhabdomyosarcoma-working out the pathways. Oncogene. 18, 5340–5348.

    Article  PubMed  CAS  Google Scholar 

  90. Kumar, R. and Hung, M. C. (2005). Signaling intricacies take center stage in cancer cells. Cancer Res. 65, 2511–2515.

    Article  PubMed  CAS  Google Scholar 

  91. Vivanco, I. and Sawyers, C. L. (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489–501.

    Article  PubMed  CAS  Google Scholar 

  92. Eskinazi, R., Thony, B., Svoboda M., et al. (1999) Overexpression of pterin-4a-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 in human colon cancer. Am. J. Pathol. 155, 1105–1113.

    PubMed  CAS  Google Scholar 

  93. Zou, Y., Lim, S., Lee, K., Deng, X., and Friedman, E. (2003) Mirk/Dyrk1B is an inhibitor of epithelial cell migration which negatively regulated by the Met-adaptor ran BPM. J. Biol. Chem. 278, 49,573–49,581.

    CAS  Google Scholar 

  94. Wang, D., Li, Z., Messing, E. M., and Wu, G. (2002) Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM. J. Biol. Chem. 277, 36,216–36,222.

    CAS  Google Scholar 

  95. Ferracini, R., Olivero, M., Di Renzo, M. F., et al. (1996) Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 12, 1697–1705.

    PubMed  CAS  Google Scholar 

  96. Sharp, R., Recio, J. A., Jhappan, C., et al. (2002) Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat. Med. 8, 1276–1280.

    Article  PubMed  CAS  Google Scholar 

  97. Takayama, H., LaRochelle, W. J., Sharp, R., et al. (1997) Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA 94, 701–706.

    Article  PubMed  CAS  Google Scholar 

  98. Yaffe, M. B. (2002) How do 14-3-3 proteins work?—Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett. 513, 53–57.

    Article  PubMed  CAS  Google Scholar 

  99. Kim, D., Won, J., Shin, D. W., et al. (2004) Regulation of Dyrk1A kinase activity by 14-3-3. Biochem. Biophys. Res. Commun. 323, 499–504.

    Article  PubMed  CAS  Google Scholar 

  100. Hawke, T. J., Meeson, A. P., Jiang, N., et al. (2003) p21 is essential for normal myogenic progenitor cell function in regenerating skeletal muscle. Am. J. Physiol. 285, C1019-C1027.

    CAS  Google Scholar 

  101. Sordella, R., Bell, D. W., Haber, D. A., and Settleman, J. (2004) Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305, 1163–1167.

    Article  PubMed  CAS  Google Scholar 

  102. Uzgare, A. R. and Isaacs, J. T. (2004) Enhanced redundancy in Akt and mitogen-activated protein kinaseinduced survival of malignant versus normal prostate epithelial cells. Cancer Res. 64, 6190–6199.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Upstate Medical University, SUNY, 750 East Adams Street, 13210, Syracuse, NY

    Stephen E. Mercer & Eileen Friedman

Authors
  1. Stephen E. Mercer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eileen Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eileen Friedman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mercer, S.E., Friedman, E. Mirk/Dyrk 1B. Cell Biochem Biophys 45, 303–315 (2006). https://doi.org/10.1385/CBB:45:3:303

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/CBB:45:3:303

Index Entries

Search

Navigation